Gene expression profile in human prostate LNCaP cancer cells by (−) epigallocatechin-3-gallate
- 13 March 2002
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 182 (1) , 43-51
- https://doi.org/10.1016/s0304-3835(02)00065-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenolsProceedings of the National Academy of Sciences, 2001
- Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), JapanCancer Letters, 2001
- Protective effect of green tea on the risks of chronic gastritis and stomach cancerInternational Journal of Cancer, 2001
- Anti‐interferon‐γ action of epigallocatechin‐3‐gallate mediated by specific inhibition of STAT1 activationThe FASEB Journal, 2001
- Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cellsOncogene, 2000
- Growth Inhibition, Cell-Cycle Dysregulation, and Induction of Apoptosis by Green Tea Constituent (-)-Epigallocatechin-3-gallate in Androgen-Sensitive and Androgen-Insensitive Human Prostate Carcinoma CellsToxicology and Applied Pharmacology, 2000
- Green Tea Polyphenol Epigallocatechin-3-Gallate Differentially Modulates Nuclear Factor κB in Cancer Cells versus Normal CellsArchives of Biochemistry and Biophysics, 2000
- Modulation of Endocrine Systems and Food Intake by Green Tea Epigallocatechin GallateEndocrinology, 2000
- Inhibition of Cell Migration, Spreading, and Focal Adhesions by Tumor Suppressor PTENScience, 1998
- Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma CellsJNCI Journal of the National Cancer Institute, 1997